Labcorp Holdings Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 13.14B | 11.86B | 12.16B | 13.01B | 13.95B | 7.2% | |
| Cost of Revenue | (8.14B) | (8.15B) | (8.80B) | (9.38B) | (10.22B) | 8.9% | |
Gross Profit | 4.99B | 3.71B | 3.36B | 3.62B | 3.73B | 3.0% | |
| Operating Expenses | |||||||
| Research & Development | — | — | (2.00M) | — | — | — | |
| Selling, General & Administrative | (1.69B) | (2.00B) | (2.02B) | (2.23B) | (2.22B) | -0.6% | |
| Depreciation & Amortization | (577.00M) | (537.20M) | (577.30M) | (643.50M) | (681.10M) | 5.8% | |
Operating Income (EBIT) | 3.05B | 1.44B | 725.60M | 1.09B | 1.52B | 39.5% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | 15.20M | — | |
| Interest Expense | (211.80M) | (179.80M) | (199.60M) | (208.30M) | (224.10M) | 7.6% | |
| Other Income/Expenses (Net) | -161.00M | -199.10M | -156.70M | -127.20M | -408.70M | 221.3% | |
Income Before Tax | 2.89B | 1.24B | 568.90M | 959.50M | 1.11B | 15.4% | |
| Income Tax Expense | (690.00M) | (233.90M) | (188.50M) | (212.40M) | (229.80M) | 8.2% | |
Net Income | 2.38B | 1.28B | 418.00M | 746.00M | 876.50M | 17.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $25 | $14 | $5 | $9 | $11 | 18.6% | |
| Weighted Avg Shares Outstanding | 96.70M | 91.10M | 87.10M | 83.90M | 83.20M | -0.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 97.50M | 91.60M | 87.60M | 84.40M | 83.80M | -0.7% | |
EBITDA | 3.68B | 1.95B | 1.35B | 1.81B | 2.01B | 11.1% |
Explore LH
LH in the Healthcare
Large Cap